| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $593.2M | +7.2% |
| Cost of Revenue | $332.5M | +5.0% |
| Gross Profit | $256.3M | +9.2% |
| R&D Expense | $40.2M | +1.8% |
| SG&A Expense | $142.8M | +0.6% |
| Operating Income | $70.3M | +35.7% |
| Interest Expense | $4.2M | -44.0% |
| Pre-tax Income | $64.0M | +84.4% |
| Income Tax | $13.1M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $54.2M | -58.3% |
| Accounts Receivable | $102.8M | -2.1% |
| Inventory | $124.6M | +5.6% |
| Current Assets | $291.4M | -19.4% |
| Total Assets | $1.05B | -6.0% |
| Current Liabilities | $105.9M | -46.4% |
| Long-term Debt | $114.0M | -43.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Capital Expenditures | $32.1M | +136.0% |
| Investing Cash Flow | -$31.6M | -169.9% |
| Financing Cash Flow | -$158.9M | -20.4% |
| +15.9% |
| Net Income | $44.2M | +118.6% |
| EPS (Basic) | $0.51 | +119.1% |
| EPS (Diluted) | $0.50 | +118.9% |
| Stockholders' Equity |
| $775.8M |
| +2.6% |